ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,702.55
-0.19%
US Tech 100
19,287.60
-0.24%
Dow Jones
42,063.36
0.09%
Brent Oil
74.445
0.76%
Bitcoin
64,419.28
1.25%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ZIOPHARM Oncology Inc (ZIOP) Quote

ZIOPHARM Oncology Inc

ZIOPHARM Oncology Inc (ZIOP)

NASDAQ
0.8657
0.00
(0.00%)
Closed September 23 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.8657
Bid
0.865
Ask
0.97
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
208.311M
Previous Close
0.8657
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
240,627,000
Dividend Yield
-
PE Ratio
-18.90
Earnings Per Share (EPS)
-0.15
Revenue
303k
Net Profit
-35.14M

About ZIOPHARM Oncology Inc

ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner I... ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad. Show more

Sector
Pharmaceutical Preparations
Industry
Spec Outpatient Facility,nec
Website
www.ziopharm.com
Headquarters
Wilmington, Delaware, USA
Founded
2016

Ask ADVFN Intelligence (AI)

ZIOP Latest News

More News

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

Phase 1/2 TCR-T Library trial targeting KRAS, TP53 and EGFR mutations across six solid tumor indications is open for enrollment; continue to expect to dose the first patient in 1H 2022 Phase 1/2...

January 26 2022
GlobeNewswire Inc.

Ziopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual Meeting

HOUSTON, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced the presentation of preclinical data highlighting the potential...

November 09 2021
GlobeNewswire Inc.

Ziopharm Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update

HOUSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced financial results for the third quarter ended September 30, 2021...

November 08 2021
GlobeNewswire Inc.

Ziopharm Oncology to Report Third Quarter Financial Results on November 8, 2021

HOUSTON, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced that it will report financial results for the third quarter ended...

November 01 2021
GlobeNewswire Inc.

Ziopharm Oncology to Participate in September Investor Conferences

BOSTON and HOUSTON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced that Kevin S. Boyle, Sr., Chief Executive Officer of...

September 01 2021
GlobeNewswire Inc.

Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions

Mr. Boyle brings over 20 years of executive business leadership in CEO, CFO and operational leadership roles Strong track record of successfully guiding companies and creating shareholder value...

August 30 2021
GlobeNewswire Inc.

Ziopharm Oncology Provides Second Quarter 2021 Corporate Updates

Accomplished key milestones in groundbreaking TCR-T Library program, including commissioning of Company’s manufacturing facility and presentation of favorable preclinical data Closed venture debt...

August 09 2021
GlobeNewswire Inc.

Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021

BOSTON, July 26, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that management will host a conference call and webcast on Monday, August 9, at 4:30 p.m. EDT to...

July 26 2021
GlobeNewswire Inc.

Ziopharm Oncology to Participate in Upcoming Conferences

BOSTON, May 24, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), a clinical-stage cellular therapy company focused on hematologic and solid tumor...

May 24 2021
GlobeNewswire Inc.

Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting

– Highlighted distinctive cellular therapy program, market opportunity and value proposition – Shared optimistic outlook and commitment to deliver value to shareholders – Encouraged by...

May 19 2021
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNZIBanzai International Inc
$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
$ 1.34
(-82.89%)
26.44M
CRBPCorbus Pharmaceuticals Holdings Inc
$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
$ 0.0855
(-42.27%)
15.05M
SKYESkye Bioscience Inc
$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
$ 116.00
(-1.59%)
377.84M
AAPLApple Inc
$ 228.20
(-0.29%)
320.78M
INTCIntel Corporation
$ 21.84
(3.31%)
261.68M
VERBVerb Technology Company Inc
$ 0.0742
(33.45%)
178.65M

Discussion

View Full Feed
rocket7878 rocket7878 3 minutes ago
Wouldn’t it be sweet if the SEC responded to the new external audits that the prior filings needed correction and that catchup be the precursor to audit approval … jump starting whatever is coming. Mr Fytton told Billy he was hoping for SEC approval a month ago this may be part of it.
GEGP
maperatpogi maperatpogi 4 minutes ago
This is good news.
However waiting for what we were told💪Name change and audited financials in September and October. Let's have them first b4 anything else. Goodness.
$IGPK/JFHE
IGPK
linkvest linkvest 8 minutes ago
Good buy... Going to run soon we bet on that one,
IGPK
shajandr shajandr 8 minutes ago
JAY PATRICK BOOTH begging to felch STEVEN MOSKOWITZ
carlson carlson 9 minutes ago
Hoping this UPCOMING WEEK is going to be EPIC!!!
NBRI
dinogreeves dinogreeves 9 minutes ago
This is will be in dollars if the data is blown out of the park and if Alzheimers is anything like their phase 2, it will go to 500-600 million market cap, they also have other indications in their pipeline.
TGRP
boobb2 boobb2 10 minutes ago
If the letter on 08/06/2024 was meant to pump up the share price ..Friedman would have sent the PR to many news outlets instead of only via the OTC...he did not....that tells he is not interested in pumping up the share price on wishful thinking and phony PR's to garner interest.......He is actual
MCIC
rocket7878 rocket7878 11 minutes ago
Hoping so - thanks for all the diligence everyone does watching for these updates. Let’s get out of these triple zeros and hope they are building something great
GEGP
EmperorMaestro47 EmperorMaestro47 12 minutes ago
Not a peep on $TAMG. Hmmm. Hey how come this stock didn't appear on market movers @ 56 % and what say you? No news and I don't read charts yet. 10q
TAMG
starkd748 starkd748 14 minutes ago
Stick to Eth Solana and Base memes....Base memes next... Solana tooker gonna blow...
Bluesky7 Bluesky7 16 minutes ago
With no news and anorexic trading for over a year, from September 10th to the close of the market on September 19th, 163,900,000 shares were purchased, and that is approx.. 25% of the total issued and outstanding share capital of the company. All of a sudden on September 10th, something or someon
PHBI
boston745 boston745 18 minutes ago
The occurrence of chronic wounds is a major global health issue. These wounds are difficult to heal as a result of disordered healing mechanisms. The most common types of chronic wounds are diabetic ulcers, pressure ulcers, arterial/venous ulcers and nonhealing surgical wounds. Although bacteria are
SINT
chrispy2468 chrispy2468 18 minutes ago
Come on 65!!
BTCUSD
VoyagerWanderer44 VoyagerWanderer44 20 minutes ago
IN April they report almost $600k record revenues. And nothing produced. on the KGKG website Clark claimed another record $1.3 million in revenues and $133k in profits last month I think it was selling LuLu Lemon which he no longer makes or sells . All a bunch of nonsense. Nothing but shenanigans.
KGKG
dinogreeves dinogreeves 20 minutes ago
"you said you don’t know whether this is a scam or not"

I wanted to be politically correct and not hurt anyones feelings.
ASII
Eli's Gone Eli's Gone 20 minutes ago
I may have to start a 3rd Survivor pool on week 6 the way I'm going LOL

I'm in a money pool one of my kids runs at his job----been going for years---last week the winner had 5 losses and this week it will be 5 or 6 losses---madness
newflow newflow 21 minutes ago
Do you remember Kirsten
https://www.youtube.com/watch?v=tRb2Hmdy4Hg
COOP
Acme Investments Acme Investments 22 minutes ago
Yes Sir!!
BTCUSD
georgejjl georgejjl 22 minutes ago
Tesla highlights the Megapack site replacing Hawaii’s last coal plant

https://www.teslarati.com/tesla-highlights-megapack-hawaii-coal/

Good luck and GOD bless,
TSLA
jedijazz jedijazz 22 minutes ago
$XXII 22ND CENTURY GROUP #95lessNICOTINE https://youtube.com/shorts/5cc7nZMLiZI?si=lUu5fgPMgLOB467E via @YouTube
XXII
fuagf fuagf 22 minutes ago
Let's see if he can answer a simple question candidly. Guessing he won't.

Your Recent History

NASDAQ
ZIOP
ZIOPHARM Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved